Position in QURE
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$7,976,149
-$3,784,342 QoQ
Shares Held
487,838
-0.7% QoQ
Ownership
0.774%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Derivatives in QURE
reported options exposure · as of Mar 31, 2026CallValue
$245,250
CallShares
15,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. QURE ranks #116 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in QURE
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,976,149 | 487,838 | Shares | Defined | 2026-05-05 | |
| 2026-03-31 | $245,250 | 15,000 | Call | Defined | 2026-05-05 | |
| 2025-12-31 | $11,760,491 | 491,454 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $11,965,206 | 204,989 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,675,531 | 263,668 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $464,202 | 33,300 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $2,405,097 | 226,896 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,539,966 | 143,826 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $24,481 | 4,966 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $22,736 | 5,075 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $138,881 | 26,708 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,137,373 | 168,002 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $580,206 | 86,469 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $194,086 | 16,936 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,702,877 | 84,552 | Shares | Defined | 2023-05-12 | |
| 2023-03-31 | $2,014,000 | 100,000 | Put | Defined | 2023-05-12 | |
| 2022-12-31 | $2,819,875 | 124,388 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $912,823 | 48,658 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,330,635 | 71,386 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $3,797,951 | 210,180 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,061,824 | 147,629 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,499,731 | 46,852 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,061,367 | 34,460 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,485,310 | 73,770 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $450,359 | 12,465 | Shares | Defined | 2021-02-11 | |
| 2020-12-31 | $238,458 | 6,600 | Put | Defined | 2021-02-11 | |
| 2020-09-30 | $243,078 | 6,600 | Put | Defined | 2020-11-12 | |
| 2020-09-30 | $1,394,162 | 37,854 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $297,396 | 6,600 | Put | Defined | 2020-07-31 | |
| 2020-06-30 | $1,108,565 | 24,602 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $1,626,917 | 34,287 | Shares | Defined | 2020-05-01 | |
| 2020-03-31 | $313,170 | 6,600 | Put | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||